Tumor microenvironment and breast cancer survival: combined effects of breast fat, M2 macrophages and hyaluronan create a dismal prognosis

被引:39
作者
Tiainen, Satu [1 ,2 ]
Masarwah, Amro [3 ]
Oikari, Sanna [4 ]
Rilla, Kirsi [4 ]
Hamalainen, Kirsi [5 ,6 ,7 ,8 ]
Sudah, Mazen [3 ]
Sutela, Anna [3 ]
Vanninen, Ritva [3 ,9 ]
Ikonen, Juho [1 ,2 ]
Tammi, Raija [4 ]
Tammi, Markku [4 ]
Auvinen, Paivi [1 ,2 ]
机构
[1] Kuopio Univ Hosp, Canc Ctr, POB 100, Kuopio 70029, Finland
[2] Univ Eastern Finland, Inst Clin Med, POB 1627, Kuopio 70211, Finland
[3] Kuopio Univ Hosp, Imaging Ctr, Clin Radiol, POB 100, Kuopio 70029, Finland
[4] Univ Eastern Finland, Inst Biomed, POB 1627, Kuopio 70211, Finland
[5] Kuopio Univ Hosp, Imaging Ctr, Clin Pathol, POB 100, Kuopio 70029, Finland
[6] Univ Eastern Finland, Inst Clin Med, Clin Pathol & Forens Med, POB 1627, Kuopio 70211, Finland
[7] Univ Eastern Finland, Bioctr Kuopio, POB 1627, Kuopio 70211, Finland
[8] Univ Eastern Finland, Canc Ctr Eastern Finland, POB 1627, Kuopio 70211, Finland
[9] Univ Eastern Finland, Inst Clin Med, Clin Radiol, POB 1627, Kuopio 70211, Finland
关键词
Breast cancer; Macrophage; Breast density; Hyaluronan; Diabetes; Obesity; ADIPOSE-TISSUE; DIABETES-MELLITUS; METFORMIN; ACCUMULATION; METAANALYSIS; DENSITY; OBESITY; RISK; ASSOCIATION; EXPRESSION;
D O I
10.1007/s10549-019-05491-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Tumor microenvironment, including inflammatory cells, adipocytes and extracellular matrix constituents such as hyaluronan (HA), impacts on cancer progression. Systemic metabolism also influences tumor growth e.g. obesity and type 2 diabetes (T2D) are risk factors for breast cancer. Here, in 262 breast cancer cases, we explored the combined impacts on survival of M2-like tumor associated macrophages (TAMs), the abundance of breast fat visualized as low density in mammograms, and tumor HA, and their associations with T2D. Methods Mammographic densities were assessed visually from the diagnostic images and dichotomized into very low density (VLD, density <= 10%, "fatty breast") and mixed density (MID, density > 10%). The amounts of TAMs (CD163+ and CD68+) and tumor HA were determined by immunohistochemistry. The data of T2D was collected from the patient records. Statistical differences between the parameters were calculated with Chi square or Mann-Whitney test and survival analyses with Cox's model. Results A combination of fatty breasts (VLD), abundance of M2-like TAMs (CD163+) and tumor HA associated with poor survival, as survival was 88-89% in the absence of these factors but only 40-47% when all three factors were present (p < 0.001). Also, an association between T2D and fatty breasts was found (p < 0.01). Furthermore, tumors in fatty breasts contained more frequently high levels of M2-like TAMs than tumors in MID breasts (p = 0.01). Conclusions Our results demonstrate a dramatic effect of the tumor microenvironment on breast cancer progression. We hypothesize that T2D as well as obesity increase the fat content of the breasts, subsequently enhancing local pro-tumoral inflammation.
引用
收藏
页码:565 / 575
页数:11
相关论文
共 48 条
[11]   Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages [J].
Ding, Ling ;
Liang, Guikai ;
Yao, Zhangting ;
Zhang, Jieqiong ;
Liu, Ruiyang ;
Chen, Huihui ;
Zhou, Yulu ;
Wu, Honghai ;
Yang, Bo ;
He, Qiaojun .
ONCOTARGET, 2015, 6 (34) :36441-36455
[12]   Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer [J].
Giles, Erin D. ;
Jindal, Sonali ;
Wellberg, Elizabeth A. ;
Schedin, Troy ;
Anderson, Steven M. ;
Thor, Ann D. ;
Edwards, Dean P. ;
MacLean, Paul S. ;
Schedin, Pepper .
BREAST CANCER RESEARCH, 2018, 20
[13]   Obesity and breast cancer: status of leptin and adiponectin in pathological processes [J].
Grossmann, Michael E. ;
Ray, Amitabha ;
Nkhata, Katai J. ;
Malakhov, Dmitry A. ;
Rogozina, Olga P. ;
Dogan, Soner ;
Cleary, Margot P. .
CANCER AND METASTASIS REVIEWS, 2010, 29 (04) :641-653
[14]   Adipocyte-derived serum amyloid A3 and hyaluronan play a role monocyte recruitment and adhesion [J].
Han, Chang Yeop ;
Subramanian, Savitha ;
Chan, Christina K. ;
Omer, Mohamed ;
Chiba, Tsuyoshi ;
Wight, Thomas N. ;
Chait, Alan .
DIABETES, 2007, 56 (09) :2260-2273
[15]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[16]   Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation [J].
Heiden, Matthew G. Vander ;
Cantley, Lewis C. ;
Thompson, Craig B. .
SCIENCE, 2009, 324 (5930) :1029-1033
[17]   Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer [J].
Iyengar, Neil M. ;
Zhou, Xi Kathy ;
Gucalp, Ayca ;
Morris, Patrick G. ;
Howe, Louise R. ;
Giri, Dilip D. ;
Morrow, Monica ;
Wang, Hanhan ;
Pollak, Michael ;
Jones, Lee W. ;
Hudis, Clifford A. ;
Dannenberg, Andrew J. .
CLINICAL CANCER RESEARCH, 2016, 22 (09) :2283-2289
[18]   Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities [J].
Jiralerspong, Sao ;
Goodwin, Pamela J. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (35) :4203-+
[19]   Mannose reduces hyaluronan and leukocytes in wound granulation tissue and inhibits migration and hyaluronan-dependent monocyte binding [J].
Jokela, Tiina A. ;
Kuokkanen, Jukka ;
Karna, Riikka ;
Pasonen-Seppanen, Sanna ;
Rilla, Kirsi ;
Kossi, Jyrki ;
Laato, Matti ;
Tammi, Raija H. ;
Tammi, Markku I. .
WOUND REPAIR AND REGENERATION, 2013, 21 (02) :247-255
[20]   Postmenopausal serum androgens, oestrogens and breast cancer risk:: the European prospective investigation into cancer and nutrition [J].
Kaaks, R ;
Rinaldi, S ;
Key, TJ ;
Berrino, F ;
Peeters, PHM ;
Biessy, C ;
Dossus, L ;
Lukanova, A ;
Binghan, S ;
Khaw, KTG ;
Allen, NE ;
Bueno-De-Mesquita, HB ;
van Gils, CH ;
Grobbee, D ;
Boeing, H ;
Lahmann, PH ;
Nagel, G ;
Chang-Claude, J ;
Clavel-Chapelon, F ;
Fournier, A ;
Thiébaut, A ;
González, CA ;
Quirós, JR ;
Tormo, MJ ;
Ardanaz, E ;
Amiano, P ;
Krogh, V ;
Palli, D ;
Panico, S ;
Tumino, R ;
Vineis, P ;
Trichopoulou, A ;
Kalapothaki, V ;
Trichopoulos, D ;
Ferrari, P ;
Norat, T ;
Saracci, R ;
Riboli, E .
ENDOCRINE-RELATED CANCER, 2005, 12 (04) :1071-1082